- CA$208.68m
- CA$275.44m
- CA$370.24m
Canada's CareRx Q1 revenue and adjusted EBITDA rise
Canada's CareRx quarterly revenue slightly beats estimates on beds serviced growth
Long-term care pharmacy CareRx Q3 revenue misses analyst expectations
Canada's CareRx Q2 revenue in-line with estimates
Brief: CareRx Reports Results For The Third Quarter Of 2024
Brief: CareRx Appoints Suzanne Brand as Chief Financial Officer
Brief: Carerx Announces Board Chair Transition And Voting Results From Annual And Special Meeting Of Shareholders
Brief: CareRx Announces CFO Transition
Brief: Carerx Corporation Establishes Automatic Share Purchase Plan
Brief: CareRx Q4 revenue CAD 91.097 million
Brief: Carerx Corporation Announces $70 Mln Debt Refinancing
Brief: CareRx Corp Revenue For Quarter Was $93.8 Million As Compared To $94.5 Million For Q2 2023
Brief: CareRx Corp Receives Regulatory Approval For Launch Of Its Normal Course Issuer Bid
Brief: CareRx Corporation Announces Intention To Launch Normal Course Issuer Bid
Brief: Carerx Reports Results For The First Quarter Of 2023
Brief: Carerx Announces CEO Transition
Brief: CareRx Corp Reports Quarterly Loss Per Share Of $0.10
Brief: CareRx Corporation Announces $16 Mln Financing Of Common Shares
Brief: CareRx Announces Retirement Of Jack Shevel As Director